XML 49 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENTS (Tables)
12 Months Ended
Dec. 31, 2023
SEGMENTS [Abstract]  
Summarized Financial Information Concerning Reportable Segments Summarized financial information concerning reportable segments is shown in the following tables:

   

Year Ended December 31, 2023

 

 (in thousands)

 

ADMA

BioManufacturing

   

Plasma Collection

Centers

   

Corporate

   

Consolidated

 

 

                       

Revenues

  $ 249,738     $ 8,334     $ 143     $ 258,215  

 

                               

Cost of product revenue

    161,157
      8,116
      -
      169,273
 

 

                               

Income (loss) from operations

    47,525       (4,048 )     (21,845 )     21,632  

 

                               

Interest and other expense, net

    (258 )     (1 )     (23,438 )     (23,697 )

 

                               
Loss on extinguishment of debt
    -       -       (26,174 )     (26,174 )
                                 

Net income (loss)

    47,267       (4,049 )     (71,457 )     (28,239 )

 

                               

Capital expenditures

    2,952       1,819       -       4,771  

Depreciation and amortization expense

    5,156       3,176       -       8,332  

Total assets

    246,719       34,733       47,730       329,182  

 

Year Ended December 31, 2022

 

  (in thousands)

 

ADMA

BioManufacturing

   
Plasma Collection
Centers
   

Corporate

   

Consolidated

 

 

                       

Revenues

  $ 144,070     $ 9,867     $ 143     $ 154,080  

 

                               

Cost of product revenue

    108,882
      9,933
      -
      118,815
 

 

                               

Income (loss) from operations

    879       (17,908 )     (22,336 )     (39,365 )

 

                               

Interest and other expense, net

    (505 )     (3 )     (19,361 )     (19,869 )
                                 
Loss on extinguishment of debt     -       -       (6,670 )     (6,670 )

 

                               

Net income (loss)

    374       (17,911 )     (48,367 )     (65,904 )

 

                               

Capital expenditures

    5,247       8,664       -       13,911  

Depreciation and amortization expense

    4,709       2,404       -       7,113  

Total assets

    238,159       37,071       73,231       348,461  
 

Year Ended December 31, 2021

 

  (in thousands)

 

ADMA

BioManufacturing

   

Plasma Collection

Centers

   

Corporate

   

Consolidated

 

 

                       

Revenues

  $ 74,936     $ 5,864     $ 143     $ 80,943  

 

                               

Cost of product revenue

    74,126       5,644       -       79,770  

 

                               

Loss from operations

    (29,294 )     (12,056 )     (17,024 )     (58,374 )

 

                               

Interest and other expense, net

    (218 )     (6 )     (13,050 )     (13,274 )
                                 

Net loss

    (29,512 )     (12,062 )     (30,074 )     (71,648 )

 

                               

Capital expenditures

    4,877       8,634       -       13,511  

Depreciation and amortization expense

    4,218       1,273       5       5,496  

Total assets

    208,391       24,682       43,180       276,253